Insider · CIK 0001352453

Blight Andrew

Reports to the SEC for 1 company · HAWTHORNE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001352453

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-03-01	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+2,036 sh	—	—	78,594
2017-03-01	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+5,090 sh	—	—	5,090
2017-02-09	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−67.6K sh	—	—	0
2017-02-09	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−67.6K sh	$22.41	−$1.51M	76,558
2017-02-09	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+67.6K sh	$22.13	+$1.5M	144,144
2016-12-01	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,855 sh	$20.76	−$101K	76,558
2016-08-09	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,754 sh	—	—	67,586
2016-08-09	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,754 sh	$22.13	+$216K	81,413
2016-03-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+20.3K sh	—	—	20,300
2015-11-20	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+500 sh	$8.50	+$4,250	72,159
2015-11-20	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−500 sh	—	—	0
2015-11-20	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−500 sh	$37.47	−$18.7K	71,659
2015-10-19	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−28.8K sh	$30.82	−$888K	75,359
2015-10-19	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,700 sh	$31.25	−$116K	71,659
2015-10-19	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+32.5K sh	$5.85	+$190K	104,159
2015-10-19	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−32.5K sh	—	—	0
2015-09-21	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,191 sh	$31.81	−$197K	71,659
2015-09-21	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,894 sh	$30.85	−$213K	77,850
2015-09-21	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+13.1K sh	$6.00	+$78.5K	84,744
2015-09-21	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−13.1K sh	—	—	0
2015-03-04	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+5,872 sh	—	—	71,659
2015-03-04	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+33.3K sh	—	—	33,278
2014-10-20	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−52.3K sh	$32.08	−$1.68M	65,787
2014-10-20	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−52.3K sh	—	—	0
2014-10-20	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+52.3K sh	$8.14	+$426K	118,125
2014-03-05	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+6,000 sh	—	—	65,787
2014-03-05	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+34K sh	—	—	34,000
2013-12-02	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−9,088 sh	$33.51	−$305K	59,787
2013-07-19	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+19.3K sh	$2.60	+$50.2K	88,171
2013-07-19	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−19.3K sh	$37.82	−$730K	68,875
2013-07-19	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−19.3K sh	—	—	0
2013-03-06	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+7,550 sh	—	—	68,875
2013-03-06	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+42.8K sh	—	—	42,785
2012-12-03	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,200 sh	$24.20	−$174K	61,325
2012-10-22	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−9,481 sh	$23.08	−$219K	68,525
2012-10-22	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,481 sh	—	—	19,296
2012-10-22	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,481 sh	$2.60	+$24.7K	78,006
2012-03-15	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+13.8K sh	—	—	68,525
2012-03-15	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+41.4K sh	—	—	41,400
2011-12-01	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,000 sh	$22.92	−$160K	54,725
2011-09-14	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+10K sh	—	—	10,000
2011-03-03	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+45K sh	—	—	45,000
2011-03-03	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+15K sh	—	—	61,725
2010-12-01	Acorda Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−5,383 sh	$26.47	−$142K	46,725
2010-03-31	Acorda Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+20K sh	—	—	52,108
2010-03-31	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+40K sh	$34.20	+$1.37M	40,000
2010-03-02	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,173 sh	$32.21	−$134K	32,108
2010-02-02	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,534 sh	$30.00	−$136K	36,281
2009-12-01	Acorda Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,500 sh	$24.51	−$110K	40,815
2009-03-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+40K sh	$20.59	+$824K	40,000

Recent filings

Accepted (ET)
Mar 34
ACORDA THERAPEUTICS INC0001209191-17-017407
SEC(opens sec.gov)
Feb 134
ACORDA THERAPEUTICS INC0001209191-17-009966
SEC(opens sec.gov)
Dec 54
ACORDA THERAPEUTICS INC0001209191-16-153395
SEC(opens sec.gov)
Aug 114
ACORDA THERAPEUTICS INC0001209191-16-136532
SEC(opens sec.gov)
Mar 44
ACORDA THERAPEUTICS INC0001209191-16-106161
SEC(opens sec.gov)
Nov 234
ACORDA THERAPEUTICS INC0001209191-15-081690
SEC(opens sec.gov)
Oct 214
ACORDA THERAPEUTICS INC0001209191-15-076350
SEC(opens sec.gov)
Sep 234
ACORDA THERAPEUTICS INC0001209191-15-071986
SEC(opens sec.gov)

Companies

Acorda Therapeutics, Inc.Chief Scientific Officer

Address

15 SKYLINE DRIVE

HAWTHORNE, NY, 10532